Gerard Evan, Ph.D. is the Sir William Dunn Professor and Head of Biochemistry at the University of Cambridge. Before Cambridge, he was the Gerson and Barbara Bass Bakar Distinguished Professor of Cancer Research at the University of California San Francisco (UCSF). His research focuses on determining the molecular basis of cancer, including studying oncogenes such as MYC.
Earlier in his career, he was at the Imperial Cancer Research Fund Laboratories in London and was elected to the Royal Society’s Napier Research Professorship. Dr. Evan studied biochemistry at Oxford, earned his Ph.D. at the MRC Laboratory of Molecular Biology in Cambridge, and completed postdoctoral studies in the laboratory of Mike Bishop at UCSF, followed by a return to Cambridge as a research fellow at Downing College. Dr. Evan was elected to EMBO in 1996, the UK Academy of Medical Sciences in 1999, the Royal Society in 2004, the European Academy of Sciences in 2006, the European Academy of Cancer Sciences in 2013, and the Academy of the American Association for Cancer Research in 2019.